One minute youre fine, the next your stomach feels tight, heavy, or justoff
In this article, we aim to answer the question, Can employers roll out GLP-1 coverage without putting a strain on their budgets? Up until recently, drugs like Ozempic were only covered by employers for diabetes treatment
These results suggest that SFN exerts an inhibitory effect on both the STAT3 and NF-B signaling pathways
Shifting Trends in Snacking Unwrapping recent snacking trends reveals that 55.1% of current GLP-1 users reported eating salty snacks daily, along with 54.4% who ate sweet snacks daily percentages have changed very little since October
In addition, we summarize recent progress in precision treatment, including chemotherapy, targeted therapy, immunotherapy, and multidisciplinary treatment
Vallof, D., Kalafateli, A